Biologic effects of interferons: relevance to multiple sclerosis

Area of Science:

• Immunology
• Molecular Biology
• Neuroscience

Background:

• Recombinant interferon beta (IFN-β) is a key therapy for relapsing-remitting multiple sclerosis (MS).
• The exact molecular mechanisms underlying IFN-β's efficacy in MS are not fully elucidated.
• Interferons exert biological effects through complex signaling cascades involving gene activation.

Purpose of the Study:

• To detail the molecular mechanisms of interferon (IFN) action.
• To explore how IFN receptor binding initiates intracellular signaling pathways.
• To discuss known IFN effects relevant to multiple sclerosis (MS) therapy.

Main Methods:

• Review of interferon (IFN) receptor-mediated gene activation pathways.
• Analysis of signal transduction from cell surface receptors to nuclear gene transcription.
• Examination of interferon-stimulated genes (ISGs) and their functions.

Main Results:

• IFN binding to receptors triggers phosphorylation and activation of cytoplasmic tyrosine kinases.
• Activated transcription factors translocate to the nucleus, interacting with the interferon-stimulated response element (ISRE).
• This process leads to the transcription of interferon-stimulated genes (ISGs), mediating IFN's biological effects.

Conclusions:

• IFN's immunomodulatory, antiviral, and antiproliferative effects are mediated by ISGs.
• The complexity arises from multiple IFN types and numerous regulated genes.
• Understanding these pathways is crucial for explaining IFN-β's therapeutic role in MS.